HIGHLIGHTS
- who: Xenofon Baraliakos and collaborators from the (UNIVERSITY) have published the Article: Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years, in the Journal: (JOURNAL)
- what: In this long-term follow-up study with AS patients treated continuously over seven years, etanercept showed a sustained efficacy and good safety profile, confirming the usage of TNF-blockers in patients with active disease.
- how: Similar data were collected for the ASDAS inactive disease status and these results were compared for each year of the study.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.